Biezeveld Maarten H, Geissler Judy, Weverling Gerrit Jan, Kuipers Irene M, Lam Jan, Ottenkamp Jaap, Kuijpers Taco W
Emma Children's Hospital, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Arthritis Rheum. 2006 Jan;54(1):369-76. doi: 10.1002/art.21529.
To evaluate the relationship between polymorphisms in the gene coding for mannose-binding lectin (MBL) and the occurrence of coronary artery lesions (CALs) among different age groups of patients with Kawasaki disease.
The frequencies of the genotypes, defined as mutations in codons 52, 54, and 57, and the functional promoter variants of the MBL2 gene were determined in 88 patients with acute Kawasaki disease (median age at onset 1.9 years). The possible influence of the MBL2 genotype on the development and progression of CALs in Kawasaki disease was assessed according to age categories and MBL genotypes in univariate and multivariate analyses.
In patients younger than age 1 year, we found an increased risk of developing CALs in the presence of a variant MBL2 genotype (P = 0.008). In contrast, in patients older than age 1 year, we found an increased risk of CALs in those patients with the wild-type genotype (P = 0.005).
Our findings indicate that MBL has an ambiguous role in Kawasaki disease and contributes differently to the pathophysiologic development of CALs, being protective in infants but potentially harmful in patients of older age. The data also imply that the standard treatment of intravenous immunoglobulins to reduce the development of lesions may not be as effective in the very young as it is in the older patients. For the very young, alternative or adjuvant treatment may be indicated, particularly in infants who are MBL-deficient.
评估编码甘露糖结合凝集素(MBL)的基因多态性与不同年龄组川崎病患者冠状动脉病变(CALs)发生之间的关系。
在88例急性川崎病患者(发病时中位年龄1.9岁)中,确定了MBL2基因密码子52、54和57处的突变所定义的基因型频率以及功能性启动子变体。在单因素和多因素分析中,根据年龄类别和MBL基因型评估MBL2基因型对川崎病中CALs发生和进展的可能影响。
在1岁以下的患者中,我们发现存在变异型MBL2基因型时发生CALs的风险增加(P = 0.008)。相比之下,在1岁以上的患者中,我们发现野生型基因型患者发生CALs的风险增加(P = 0.005)。
我们的研究结果表明,MBL在川崎病中具有不明确的作用,对CALs的病理生理发展有不同的影响,对婴儿有保护作用,但对年龄较大的患者可能有害。数据还表明,静脉注射免疫球蛋白减少病变发生的标准治疗在非常年幼的患者中可能不如在年龄较大的患者中有效。对于非常年幼的患者,可能需要替代或辅助治疗,特别是对于MBL缺陷的婴儿。